Compounds > fludarabine

fludarabine and Lymphohistiocytosis, Hemophagocytic

fludarabine has been researched along with Lymphohistiocytosis, Hemophagocytic in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (21.05)29.6817
2010's15 (78.95)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jin, JG1
Algeri, M; Aricò, M; Basso, G; Caniglia, M; Cesaro, S; Di Bartolomeo, P; Fagioli, F; Favre, C; Giardino, S; Locatelli, F; Marzollo, A; Merli, P; Messina, C; Pillon, M; Porta, F; Prete, A; Rabusin, M; Ripaldi, M; Rovelli, A; Saglio, F; Sieni, E; Zecca, M; Ziino, O1
Choo, S; Cole, T; Mechinaud, F; Richards, S1
Bredius, RGM; Bresters, D; Jacobse, J; Kollen, WJW; Mensink, H; van der Stoep-Yap, MYEC1
Allen, CE; Andolina, JR; Baker, KS; Bollard, CM; Bryant, C; Burroughs, L; Connelly, J; Dawson, P; Eapen, M; Hanna, R; Kean, L; Marsh, R; Pai, SY; Pulsipher, MA; Ramirez, A; Roehrs, P; Schultz, KR; Shenoy, S; Stenger, EO; Talano, JA1
Behfar, M; Fazlollahi, MR; Ghavamzadeh, A; Hamidieh, AA; Hashemi, S; Moin, M; Pourpak, Z; Yari, K1
Atsuta, Y; Goto, H; Inagaki, J; Inoue, M; Ishii, E; Kato, K; Kawa, K; Koike, K; Ohga, S; Okada, K; Sawada, A; Suzuki, N; Suzuki, R; Yabe, H; Yasutomo, K1
Behfar, M; Fazlollahi, MR; Ghavamzadeh, A; Hamidieh, AA; Hashemi, S; Moin, M; Movahedi, M; Pourpak, Z; Yari, K1
Imamura, Y1
Carey, P; Hurst, E; Jayakody Arachchillage, D; Keenan, F; Menne, T; Moses, S; O'Brien, SG; Wallis, JP1
Bleesing, JJ; Davies, SM; Filipovich, AH; Haines, HL; Hornung, L; Jordan, MB; Marsh, RA1
Delgado, D; Hege, K; Quigg, T1
Ayala, E; Kharfan-Dabaja, MA; LaFave, D; Nishihori, T1
Chen, X; Tian, LP; Wang, JS; Wang, Z; Wu, L1
Bot, FJ; Chaker, L; Maartense, E; Segeren, CM1
Adachi, S; Fujita, N; Ishii, E; Kanai, R; Nishi, M; Nishimura, R; Ohga, S; Okamura, T; Sato, E; Sawada, A; Suzuki, N; Yano, J; Yasumi, T; Yasutomo, K1
Cantu-Rodríguez, O; Gomez-Almaguer, D; Gonzalez-Llano, O; Gutierrez-Aguirre, H; Herrera-Garza, J; Jaime-Pérez, J; Mancias-Guerra, C1
Attarbaschi, A; Fritsch, G; Gadner, H; Lawitschka, A; Lion, T; Matthes-Martin, S; Minkov, M; Mittheisz, E; Steiner, M; Zoubek, A1
Goto, H; Ito, S; Kajiwara, R; Kuroki, F; Yanagimachi, M; Yokosuka, T; Yokota, S1

Reviews

1 review(s) available for fludarabine and Lymphohistiocytosis, Hemophagocytic

ArticleYear
[Hemophagocytic lymphohistiocytosis].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2014, Volume: 55, Issue:2

    Topics: Antibodies, Monoclonal, Murine-Derived; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Cyclosporine; Disease Progression; Doxorubicin; Drug Therapy, Combination; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphohistiocytosis, Hemophagocytic; Methotrexate; Multiple Organ Failure; Prednisolone; Prednisone; Rituximab; Severity of Illness Index; Transplantation Conditioning; Vidarabine; Vincristine

2014

Trials

2 trial(s) available for fludarabine and Lymphohistiocytosis, Hemophagocytic

ArticleYear
Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies.
    Blood, 2018, 09-27, Volume: 132, Issue:13

    Topics: Adolescent; Adult; Alemtuzumab; Antineoplastic Agents; Child; Child, Preschool; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Lymphohistiocytosis, Hemophagocytic; Male; Melphalan; Survival Analysis; Transplantation Conditioning; Treatment Outcome; Vidarabine; Young Adult

2018
Feasibility of reduced-intensity conditioning followed by unrelated cord blood transplantation for primary hemophagocytic lymphohistiocytosis: a nationwide retrospective analysis in Japan.
    International journal of hematology, 2013, Volume: 98, Issue:2

    Topics: Adolescent; Allografts; Antilymphocyte Serum; Child; Child, Preschool; Cord Blood Stem Cell Transplantation; Disease-Free Survival; Female; Humans; Immunosuppressive Agents; Infant; Japan; Lymphohistiocytosis, Hemophagocytic; Male; Melphalan; Myeloablative Agonists; Survival Rate; Transplantation Conditioning; Unrelated Donors; Vidarabine

2013

Other Studies

16 other study(ies) available for fludarabine and Lymphohistiocytosis, Hemophagocytic

ArticleYear
Fludarabine is effective in treating refractory hemophagocytic lymphohistiocytosis with brucellosis.
    International journal of rheumatic diseases, 2017, Volume: 20, Issue:12

    Topics: Anti-Bacterial Agents; Brucellosis; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Treatment Outcome; Vidarabine

2017
Outcomes of Children with Hemophagocytic Lymphohistiocytosis Given Allogeneic Hematopoietic Stem Cell Transplantation in Italy.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2018, Volume: 24, Issue:6

    Topics: Adolescent; Busulfan; Child; Child, Preschool; Female; Graft Rejection; Hematopoietic Stem Cell Transplantation; Histocompatibility; Humans; Infant; Italy; Lymphohistiocytosis, Hemophagocytic; Male; Recurrence; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine

2018
Single centre results of targeted busulphan, fludarabine and serotherapy conditioning in haematopoietic stem cell transplantation for haemophagocytic lymphohistiocytosis.
    Bone marrow transplantation, 2018, Volume: 53, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Busulfan; Combined Modality Therapy; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunization, Passive; Lymphohistiocytosis, Hemophagocytic; Male; Transplantation Conditioning; Vidarabine

2018
Long-term aprepitant for nausea and vomiting associated with gastroparesis in hematopoietic stem cell transplantation.
    Bone marrow transplantation, 2018, Volume: 53, Issue:10

    Topics: Alemtuzumab; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Busulfan; Cyclosporine; Gastroparesis; Hematopoietic Stem Cell Transplantation; Humans; Infant; Lymphohistiocytosis, Hemophagocytic; Male; Methotrexate; Nausea; Unrelated Donors; Vidarabine; Vomiting

2018
Hematopoietic stem cell transplantation with a reduced-intensity conditioning regimen in pediatric patients with Griscelli syndrome type 2.
    Pediatric transplantation, 2013, Volume: 17, Issue:5

    Topics: Child, Preschool; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Immune System; Immunologic Deficiency Syndromes; Infant; Lymphohistiocytosis, Hemophagocytic; Male; Myeloablative Agonists; Piebaldism; Primary Immunodeficiency Diseases; Prospective Studies; Tissue Donors; Transplantation Conditioning; Treatment Outcome; Vidarabine

2013
Fludarabine-based reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in primary hemophagocytic lymphohistiocytosis.
    European journal of haematology, 2014, Volume: 92, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Lymphohistiocytosis, Hemophagocytic; Male; Myeloablative Agonists; Prospective Studies; Transplantation Chimera; Transplantation Conditioning; Treatment Outcome; Vidarabine

2014
Haemophagocytic lymphohistiocytosis following fludarabine/cyclophosphamide chemotherapy for chronic lymphocytic leukaemia.
    British journal of haematology, 2014, Volume: 166, Issue:1

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Fatal Outcome; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Vidarabine

2014
Outcomes of donor lymphocyte infusion for treatment of mixed donor chimerism after a reduced-intensity preparative regimen for pediatric patients with nonmalignant diseases.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2015, Volume: 21, Issue:2

    Topics: Adolescent; Alemtuzumab; Antibodies, Monoclonal, Humanized; Child; Child, Preschool; Chimerism; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Lymphocyte Transfusion; Lymphohistiocytosis, Hemophagocytic; Lymphoproliferative Disorders; Male; Melphalan; Mucopolysaccharidoses; Myeloablative Agonists; Retrospective Studies; Severe Combined Immunodeficiency; Siblings; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Unrelated Donors; Vidarabine

2015
Alemtuzumab, Fludarabine, Low-Dose TBI, and Double Umbilical Cord Transplant for Primary Graft Failure in a Patient with Recurrent HLH.
    Pediatric blood & cancer, 2016, Volume: 63, Issue:2

    Topics: Alemtuzumab; Antibodies, Monoclonal, Humanized; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; Graft vs Host Disease; Humans; Infant; Lymphohistiocytosis, Hemophagocytic; Male; Recurrence; Salvage Therapy; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation

2016
Haploidentical transplantation as a promising therapy for relapsed hemophagocytic lymphohistiocytosis in an older adult patient.
    Hematology/oncology and stem cell therapy, 2018, Volume: 11, Issue:2

    Topics: Aged; Allografts; Cyclophosphamide; Hematopoietic Stem Cell Transplantation; Humans; Lymphohistiocytosis, Hemophagocytic; Male; Mycophenolic Acid; Tacrolimus; Transplantation Conditioning; Vidarabine

2018
[Clinical analysis of 14 patients with lymphoma associated hemophagocytic syndrome].
    Zhongguo shi yan xue ye xue za zhi, 2009, Volume: 17, Issue:5

    Topics: Humans; Lymphohistiocytosis, Hemophagocytic; Lymphoma; Prognosis; Retrospective Studies; Treatment Outcome; Vidarabine

2009
Haemophagocytic syndrome and Hodgkin's disease variant of Richter's syndrome after fludarabine for CLL.
    European journal of haematology, 2010, Volume: 85, Issue:1

    Topics: Aged; Antineoplastic Agents; Epstein-Barr Virus Infections; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphohistiocytosis, Hemophagocytic; Male; Vidarabine

2010
Reduced-intensity conditioning in unrelated donor cord blood transplantation for familial hemophagocytic lymphohistiocytosis.
    American journal of hematology, 2012, Volume: 87, Issue:6

    Topics: Blood Component Transfusion; Blood Donors; Child, Preschool; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; Disease-Free Survival; Female; Graft Survival; Graft vs Host Disease; Humans; Infant; Infant, Newborn; Japan; Lymphohistiocytosis, Hemophagocytic; Male; Melphalan; Reoperation; Retrospective Studies; Salvage Therapy; Transplantation Conditioning; Treatment Outcome; Vidarabine; Whole-Body Irradiation

2012
Successful father-to-son stem cell transplantation in a child with hemophagocytic lymphohistiocytosis using a reduced-intensity conditioning regimen.
    European journal of haematology, 2006, Volume: 77, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Etoposide; Family; Graft vs Host Disease; Humans; Infant; Lymphohistiocytosis, Hemophagocytic; Magnetic Resonance Imaging; Male; Melphalan; Methotrexate; Stem Cell Transplantation; Transplantation Conditioning; Vidarabine

2006
Importance of allogeneic T-cells for disease control after stem cell transplantation for high-risk Langerhans cell histiocytosis.
    Haematologica, 2007, Volume: 92, Issue:1

    Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Bone Marrow Transplantation; Combined Modality Therapy; Drug Therapy, Combination; Etoposide; Female; Graft Survival; Histiocytosis, Langerhans-Cell; Humans; Infant; Lymphocyte Transfusion; Lymphohistiocytosis, Hemophagocytic; Melphalan; Prednisone; Remission Induction; T-Lymphocyte Subsets; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Vinblastine

2007
[Reactivation of familial hemophagocytic lymphohistiocytosis after non-myeloablative cord blood stem cell transplantation resulted in the early graft failure].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2007, Volume: 48, Issue:6

    Topics: Antilymphocyte Serum; Child, Preschool; Cord Blood Stem Cell Transplantation; DNA; Female; Graft Rejection; Histocompatibility Testing; Humans; Killer Cells, Natural; Lymphocyte Activation; Lymphohistiocytosis, Hemophagocytic; Recurrence; T-Lymphocytes; Transplantation Conditioning; Vidarabine

2007